Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Trius Therapeutics
Trius Therapeutics
Antibiotic Companies To Cash In On In 2014
Seeking Alpha
Thu, 02/13/14 - 09:25 am
antibiotics
Optimer Pharmaceuticals
Trius Therapeutics
Solithromycin
Cempra
How Cellceutix Acquired A Next Generation Antibiotic For Pennies On The Dollar
Seeking Alpha
Fri, 09/13/13 - 09:13 am
Cellceutix
antibiotics
Organovo
Cubist Pharmaceuticals
Celgene
Trius Therapeutics
Tetraphase Pharmaceuticals
Pfizer
MRSA
Optimer Pharmaceuticals
Dificid
Brilacidin
Cubist Pharmaceuticals Completes Acquisition of Trius Therapeutics
Yahoo
Thu, 09/12/13 - 09:28 am
Cubist Pharmaceuticals
Trius Therapeutics
Cubist Receives Antitrust Clearance for Trius Purchase
Motley Fool
Fri, 08/30/13 - 08:52 am
Trius Therapeutics
Cubist Pharmaceuticals
M&A
Trius Acquired Last Week, Tetraphase Could Be Next
Seeking Alpha
Tue, 08/6/13 - 10:19 am
Trius Therapeutics
M&A
Tetraphase Pharmaceuticals
Cubist Pharmaceuticals
Optimer Pharmaceuticals
Pfizer
SHAREHOLDER ALERT: Levi & Korsinsky Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Trius Therapeutics, Inc. in Connection with the Sale of Company to Cubist Pharmaceuticals, Inc.
Yahoo/BusinessWire
Wed, 07/31/13 - 09:54 am
Cubist Pharmaceuticals
Trius Therapeutics
M&A
lawsuits
Cubist Pharmaceuticals to Acquire Trius Therapeutics
Yahoo/BusinessWire
Wed, 07/31/13 - 09:51 am
Cubist Pharmaceuticals
Trius Therapeutics
M&A
The Best- And Worst-Performing Biotech Stocks July 5 To July 12
Forbes
Mon, 07/15/13 - 11:58 am
Vivus
Trius Therapeutics
Prosensa
Pharmacyclics
NxStage Medical
Natus Medical
MiMedx
Merrimack Pharmaceuticals
Intuitive Surgical
InterMune
GTx
Fluidigm
Epizyme
Celldex
Astex
Analogic
Amarin
Alnylam
Alexion
AcelRx
Cempra's Platform Potentially Worth Billions In Battling Superbugs And MRSA
Seeking Alpha
Tue, 06/25/13 - 12:20 pm
Cempra
superbugs
Cubist Pharmaceuticals
Ariad Pharmaceuticals
Celldex
Trius Therapeutics
Trius Therapeutics: New, Positive Dimension For Investment Outlook
Seeking Alpha
Tue, 05/14/13 - 08:37 am
Trius Therapeutics
Teva
Cubist Pharmaceuticals
GTx And Trius Therapeutics: 2 Top Biotech Buys For 2013
Seeking Alpha
Thu, 04/18/13 - 08:05 am
GTx
Trius Therapeutics
enobosarm
TR-701
Companies That Can Mend The Biotech Market: Stephen Brozak
Seeking Alpha
Sat, 04/13/13 - 11:36 am
Trius Therapeutics
NuPathe
Navidea Biopharmaceuticals
Cytori
Cempra
Cardinal Health
BioTime
Alexza Pharmaceuticals
Aastrom Biosciences
Trius Therapeutics Is A Strong Investment Short And Long Term
Seeking Alpha
Fri, 03/22/13 - 10:47 am
Trius Therapeutics
tedizolid
Trius Therapeutics: Takeover Candidate In 2013
Seeking Alpha
Mon, 02/4/13 - 12:13 pm
Trius Therapeutics
Cubist Pharmaceuticals
M&A
Trius: Tedizolid Prospects In MRSA Lead To Initiation With A Buy
Seeking Alpha
Fri, 06/1/12 - 10:27 am
Trius Therapeutics
MRSA
tedizolid
antibiotics
Trius Therapeutics plans stock offering
Yahoo/AP
Wed, 01/25/12 - 05:26 pm
Trius Therapeutics
stock offering
Trius reports on late-stage study for lead product
Yahoo/AP
Mon, 12/19/11 - 04:01 pm
Trius Therapeutics
Zyvox
Prizer
MRSA
tedizolid
Drug-Resistant Germs Lure Biotechs to Lead Antibiotics Effort
Bloomberg
Tue, 05/17/11 - 09:51 am
antibiotics
biotech
Dificid
Optimer
Trius Therapeutics
Cubist Pharmaceuticals
Medicines Company
Trius, Ariad Show Interesting Pipeline Potential
Seeking Alpha
Sun, 10/24/10 - 01:33 pm
Trius Therapeutics
Ariad Pharmaceuticals
rapamycin
mTOR inhibitors
Two IPOs Brave the Markets, Two Enter the Queue: Biotech's Latest Deals
Seeking Alpha
Sun, 08/8/10 - 01:18 pm
Trius Therapeutics
Torezolid
Pfizer
linezolid
skin infection
NuPathe
Zelrix
migraines
Complete Genomics
Horizon Pharma
Pages
1
2
next ›
last »